NBTX - Nanobiotix Short-Term Debt to Capital

Symbol and logo of brand Nanobiotix Corp (NBTX)

Nanobiotix S.A. (NBTX) is implementing automation in particle synthesis and utilizing software robots for test analysis. The operating model relies on external contractors for production and logistics. The price visualization on GURU.Markets for the separate_debt_short_eq metric stands at 0.00. The business seeks pricing power through unique nanoparticles that physically destroy neoplasms during irradiation while preserving healthy tissues.

Current Liabilities to Capital: Nanobiotix Corp (NBTX) for 07/04/2022 - 11/01/2026

Summary analytical data breakdowns for nanobiotix.com (NBTX)

- stock value and consensus price forecast:
Price Chart Nanobiotix Corp|NBTX - Broker Consensus Forecast
- market capitalization statistics:
Market Capitalization Nanobiotix SA|NBTX - Real Price to Acquire Entire Company
- book capitalization information:
Net Assets per Single Share Nanobiotix|NBTX - Total Stockholders' Equity|Market Value to Book Value Ratio nanobiotix.com|NBTX - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Nanobiotix S.A.|NBTX - Long-Term Liabilities to Capital|Short-Term Debt to Capital Nanobiotix|NBTX - Company Total Indebtedness|Debt to Book Value Nanobiotix SA|NBTX - Long-Term Debt|Company Current Liabilities Nanobiotix|Quick Liquidity nanobiotix.com
- company profitability and valuation multiples indicators:
NBTX - Profit After Tax
Initial company analysis:Nanobiotix Corp NBTX
Signature product of nanobiotix.com

The stability of Nanobiotix S.A. (NBTX) relies on low operating expenses, including standard bio-waste control, which minimizes the need for emergency financing. By analyzing the history of short-term loans to capital, an investor assesses the share of liabilities under one year relative to equity: a high dependence on "short" money may signal liquidity risk, whereas moderate leverage confirms the fair value of assets.

Competitors of Nanobiotix S.A. (NBTX)

Short-Term Debt to Equity Geron Corp. (GERN)|Bicycle Corp - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital CTMX (CytomX Therapeutics)|CATX - Short-Term Debt to Equity Ratio|GNLX - Short-Term Debt to Equity|Current Liabilities to Capital Molecular Partners Ltd|oncolyticsbiotech.com (ONCY) - Short-Term Debt to Equity|LSTA (Lisata Therapeutics, Inc.) - Short-Term Debt to Equity|Short-Term Debt to Equity Moleculin Biotech Inc|Current Liabilities to Capital Galera GRTX|Short-Term Debt to Capital MTEM